Back to the main directory
Press Release
- NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic by GlobeNewsWire
- Ferrellgas, L.P. Announces Add-On Offering of 10.000% Senior Secured First Lien Notes Due 2025 by GlobeNewsWire
- Burlington Stores, Inc. Provides COVID-19-Related Business Update by GlobeNewsWire
- Burlington Stores, Inc. Announces Proposed Offering of Senior Secured Notes by GlobeNewsWire
- Eloxx Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on May 7, 2020 by GlobeNewsWire
- BrainsWay Announces Preliminary Revenue Range for First Quarter of 2020 by GlobeNewsWire
- Zix to Announce First Quarter 2020 Results on May 6 by BusinessWire
- AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting by BusinessWire
- Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan by GlobeNewsWire
- Altus Group Announces Change to Location of Annual and Special Meeting of Shareholders on May 6, 2020 by GlobeNewsWire
- Patriot One Hires New Chief Operating Officer & President Dietmar Wennemer by GlobeNewsWire
- CPI Aerostructures Secures $4.8 Million Loan Under Paycheck Protection Program Provision of Cares Act by GlobeNewsWire
- Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency by GlobeNewsWire
- Desert Gold Options Non-core Djimbala Property in Southern Mali to Indigo by Newsfile Corp.
- Freeport-McMoRan Provides Update on Cerro Verde Mine in Peru by BusinessWire
- SilverCrest Announces C$75 Million Non-Brokered Private Placement by Newsfile Corp.
- Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials by GlobeNewsWire
- Laureate Education Announces Date of First Quarter 2020 Earnings Release and Conference Call by GlobeNewsWire
- Groupon Adopts Limited Duration Shareholder Rights Plan by BusinessWire
- OSS Initiates $3 Million Reorganization and Expense Reduction Program to Support Long-term Sustainability and Future Growth by GlobeNewsWire
- La Jolla Pharmaceutical Company to Provide GIAPREZAâ„¢ (Angiotensin II) for Emergency Medical Program in Patients with Septic Shock Due to COVID-19 at CHIREC Delta Hospital, Brussels, Belgium by GlobeNewsWire
- Ideal Power to Host Business Update Conference Call on Tuesday, April 14, 2020 at 4:30 p.m. Eastern Time by GlobeNewsWire
- Tauriga Sciences Inc. Approved by ALIBABA to List its Cannabigerol Infused Version of Tauri-Gum on Alibaba.com by GlobeNewsWire
- HyperSolar’s China Connections Accelerate Production of Renewable Solar Hydrogen Panels by GlobeNewsWire
- Alimera Sciences Pre-Announces Expected Top Line Revenue for Q1 2020 and Provides COVID-19 Business Update by GlobeNewsWire